Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,16 USD | +0,53% | -6,48% | -30,39% |
21/03 | VIRIDIAN THERAPEUTICS, INC. : B. Riley ontvangt een koopadvies | ZM |
28/02 | VIRIDIAN THERAPEUTICS, INC. : Wedbush ontvangt een koopadvies | ZM |
Omzet 2024 * | 307K 288K | Omzet 2025 * | 3,11 mln. 2,91 mln. | Marktkapitalisatie | 952 mln. 893 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -266 mln. -249 mln. | Nettowinst (verlies) 2025 * | -293 mln. -275 mln. | EV/omzet 2024 * | 1.737 x |
Nettoliquiditeiten 2024 * | 418 mln. 392 mln. | Nettoliquiditeiten 2025 * | 587 mln. 551 mln. | EV/omzet 2025 * | 117 x |
K/w-verhouding 2024 * |
-3,45
x | K/w-verhouding 2025 * |
-3,49
x | Werknemers | 94 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,57% |
Recentste transcriptie over Viridian Therapeutics, Inc.
1 dag | +0,53% | ||
1 week | -6,48% | ||
Lopende maand | -13,42% | ||
1 maand | -12,57% | ||
3 maanden | -24,73% | ||
6 maanden | +28,15% | ||
Lopend jaar | -30,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 30-10-23 | |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 01-05-23 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 03-01-18 |
Tomas Kiselak
CHM | Chairman | 38 | 28-10-20 |
Chief Executive Officer | 53 | 30-10-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.06% | 237 M€ | -1,30% | - | |
0.02% | 2 M€ | -.--% | ||
0.01% | 773 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 15,16 | +0,53% | 580 684 |
17-04-24 | 15,08 | -0,07% | 661 453 |
16-04-24 | 15,09 | -3,52% | 679 991 |
15-04-24 | 15,64 | -1,57% | 881 394 |
12-04-24 | 15,89 | -1,97% | 773 632 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,39% | 952 mln. | |
-1,82% | 41,35 mld. | |
+42,66% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |